glp-1 alcohol abuse Agonists for Use Disorder: UK Evidence and Guidance GLP-1 Alcohol Cravings: How Ozempic

Tashiro Y, Sato K, Watanabe T, Nohtomi K, Terasaki M, Nagashima M, Hirano T: A glucagon-like peptide-1 analog liraglutide suppresses macrophage foam cell formation and atherosclerosis

Diabetic kidney disease research: where do we stand at the turn of the century

In preclinical models, these molecules improve bone mass [107], trabecular and cortical architecture [109111], bone strength [112], and collagen content [111], but do not affect bone mineral density [113115]

Since a high dose of semaglutide (0.1 mg/kg) was examined 17 when using the drug in animals to reduce alcohol-seeking behavior, adjusting the dosage to obtain the desired effect while decreasing the potentially harmful effects is recommended